Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Reproduction

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/REP.0.1240625PMID 12417000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway.

  2002cited by this paper
• 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes.

  2002cited by this paper
• Cyclopentenone prostaglandins: New insights on biological activities and cellular targets

  2001cited by this paper
• Modulation of PGE2 generation in the diabetic embryo: effect of nitric oxide and superoxide dismutase.

  2001cited by this paper
• Requirement of nitric oxide for murine oocyte maturation, embryo development, and trophoblast outgrowth in vitro

  2001cited by this paper
• Diacylglycerol generated in CHO cell plasma membrane by phospholipase C is used for triacylglycerol synthesis.

  2001cited by this paper
• Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.

  2001cited by this paper
• Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women.

  2001cited by this paper
• Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.

  2001cited by this paper
• Dysregulation of Fatty Acid Metabolism in the Etiology of Type 2 Diabetes

  2001cited by this paper
• Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase

  2000cited by this paper
• The LDL receptor gene family, apolipoprotein B and cholesterol in embryonic development.

  1999cited by this paper
• Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.

  1999cited by this paper
• Increased prostaglandin E generation and enhanced nitric oxide synthase activity in the non-insulin-dependent diabetic embryo during organogenesis.

  1998cited by this paper
• Cholesterol metabolism and embryogenesis.

  1998cited by this paper
• The nuclear receptor PPARgamma - bigger than fat.

  1998cited by this paper
• The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

  1998cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity.

  1997cited by this paper
• A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice.

  1996cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more....

  1995cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• Glucose metabolism, triglyceride and glycogen levels, as well as eicosanoid production in isolated uterine strips and in embryos in a rat model of non-insulin-dependent diabetes mellitus during pregnancy.

  1994cited by this paper
• Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats.

  1994cited by this paper
• Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine.

  1994cited by this paper
• Effects of a New Oral Hypoglycaemic Agent (CS‐045) on Metabolic Abnormalities and Insulin Resistance in Type 2 Diabetes

  1994cited by this paper
• Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome.

  1993influential reference
• Diabetic Embryopathy Studies With Animal and In Vitro Models

  1991cited by this paper
• Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine.

  1988cited by this paper
• Placental function in maternal-fetal fat transport in diabetes.

  1987cited by this paper
• Physiologic and cellular insulin action in a glucose-intolerant model of Type 2 (non-insulin-dependent) diabetes in rats

  1986cited by this paper
• Teratogenic Effect of AY 9944 in Rats: Importance of the Day of Administration and Maternal Plasma Cholesterol Level

  1984cited by this paper
• Effects of maternal diabetes on the levels, synthetic rates and activities of synthetic enzymes of surface-active phospholipids in perinatal rat lung.

  1983influential reference
• Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

  1982cited by this paper
• Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes

  1979cited by this paper
• Diabetic pregnancy and perinatal morbidity.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976influential reference
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Evidence for Quercetin as a Dietary Supplement for the Treatment of Cardio-Metabolic Diseases in Pregnancy: A Review in Rodent Models

  2022cites this paper
• Modulation of nuclear factor‐&kgr;B signaling and reduction of neural tube defects by quercetin‐3‐glucoside in embryos of diabetic mice

  2018cites this paper
• Reduction in Embryonic Malformations and Alleviation of Endoplasmic Reticulum Stress by Nitric Oxide Synthase Inhibition in Diabetic Embryopathy

  2012cites this paper
• The Role of Oxidative Stress in the Pathophysiology of Gestational Diabetes Mellitus

  2011cites this paper
• Animal models in diabetes and pregnancy.

  2010cites this paper
• MMP/ TIMP balance is modulated in vitro by 15dPGJ2 in fetuses and placentas from diabetic rats

  2009cites this paper
• Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats.

  2008cites this paper
• The effects of maternal dietary treatments with natural PPAR ligands on lipid metabolism in fetuses from control and diabetic rats.

  2008cites this paper
• Peroxisome proliferator-activated receptor alpha activation regulates lipid metabolism in the feto-placental unit from diabetic rats.

  2008cites this paper
• PPAR d and its activator PGI 2 are reduced in diabetic embryopathy: involvement of PPAR d activation in lipid metabolic and signalling pathways in rat embryo early organogenesis

  2007influential citation
• PPARdelta and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis.

  2007cites this paper
• Leptin in embryos from control and diabetic rats during organogenesis: a modulator of nitric oxide production and lipid homeostasis

  2007cites this paper
• Leptin modulates nitric oxide production and lipid metabolism in human placenta.

  2006cites this paper
• Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment.

  2006cites this paper
• Effect of prostaglandins against alloxan-induced diabetes mellitus.

  2006cites this paper
• Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis.

  2005influential citation
• 15-Deoxy-Δ12,14-prostaglandin J2 and peroxisome proliferator-activated receptor γ (PPARγ) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARγ agonist on nitridergic and lipid placental metabolism

  2005cites this paper
• 15-Deoxy-Delta12,14-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism.

  2005cites this paper
• The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy.

  2005cites this paper
• Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women.

  2004cites this paper
• Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro.

  2004cites this paper
• Modulatory effect of leptin on nitric oxide production and lipid metabolism in term placental tissues from control and streptozotocin-induced diabetic rats.

  2004cites this paper